BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Q, Ba-Alawi W, Deblois G, Cruickshank J, Duan S, Lima-Fernandes E, Haight J, Tonekaboni SAM, Fortier AM, Kuasne H, McKee TD, Mahmoud H, Kushida M, Cameron S, Dogan-Artun N, Chen W, Nie Y, Zhang LX, Vellanki RN, Zhou S, Prinos P, Wouters BG, Dirks PB, Done SJ, Park M, Cescon DW, Haibe-Kains B, Lupien M, Arrowsmith CH. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nat Commun 2020;11:4205. [PMID: 32826891 DOI: 10.1038/s41467-020-18020-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Fukano M, Park M, Deblois G. Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers (Basel) 2021;13:4699. [PMID: 34572926 DOI: 10.3390/cancers13184699] [Reference Citation Analysis]
2 Song K, Rajasekaran N, Chelakkot C, Lee HS, Paek SM, Yang H, Jia L, Park HG, Son WS, Kim YJ, Choi JS, Jeong HM, Suh YG, Yun H, Shin YK. Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH. Pharmaceuticals (Basel) 2021;14:1060. [PMID: 34681284 DOI: 10.3390/ph14101060] [Reference Citation Analysis]
3 Fong Z, Lee WL. An emerging role of KRAS in biogenesis, cargo sorting and uptake of cancer-derived extracellular vesicles. Future Med Chem 2022. [PMID: 35502655 DOI: 10.4155/fmc-2021-0332] [Reference Citation Analysis]
4 Miao J, Zhang L, Gao P, Zhao H, Xie X, Wang J. Chitosan-Based Glycolipid Conjugated siRNA Delivery System for Improving Radiosensitivity of Laryngocarcinoma. Polymers (Basel) 2021;13:2929. [PMID: 34502969 DOI: 10.3390/polym13172929] [Reference Citation Analysis]
5 Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov 2021. [PMID: 34862480 DOI: 10.1038/s41573-021-00339-6] [Reference Citation Analysis]
6 Cava C, Sabetian S, Castiglioni I. Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data. Entropy (Basel) 2021;23:225. [PMID: 33670375 DOI: 10.3390/e23020225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Guerra B, Recio C, Aranda-Tavío H, Guerra-Rodríguez M, García-Castellano JM, Fernández-Pérez L. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy. Front Oncol 2021;11:626971. [PMID: 33718197 DOI: 10.3389/fonc.2021.626971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sun S, Zhang Y, Xu W, Yang R, Yang Y, Guo J, Ma Q, Ma K, Zhang J, Xu J. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells. Biomed Pharmacother 2021;146:112546. [PMID: 34954641 DOI: 10.1016/j.biopha.2021.112546] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Papalazarou V, Maddocks ODK. Supply and demand: Cellular nutrient uptake and exchange in cancer. Mol Cell 2021;81:3731-48. [PMID: 34547236 DOI: 10.1016/j.molcel.2021.08.026] [Reference Citation Analysis]
10 Qiu BQ, Lin XH, Lai SQ, Lu F, Lin K, Long X, Zhu SQ, Zou HX, Xu JJ, Liu JC, Wu YB. ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation. Cancer Cell Int 2021;21:665. [PMID: 34906142 DOI: 10.1186/s12935-021-02380-2] [Reference Citation Analysis]
11 Hossain F, Majumder S, David J, Miele L. Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions. Cancers (Basel) 2021;13:3739. [PMID: 34359640 DOI: 10.3390/cancers13153739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang CC. Metabolic Stress Adaptations Underlie Mammary Gland Morphogenesis and Breast Cancer Progression. Cells 2021;10:2641. [PMID: 34685621 DOI: 10.3390/cells10102641] [Reference Citation Analysis]
13 Tőkés AM, Vári-kakas S, Kulka J, Törőcsik B. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas. Front Oncol 2022;12:850401. [DOI: 10.3389/fonc.2022.850401] [Reference Citation Analysis]
14 Zhang X, Pang X, Zhang Z, Liu Q, Zhang H, Xiang Q, Cui Y. Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer. BMC Cancer 2021;21:1026. [PMID: 34525987 DOI: 10.1186/s12885-021-08763-y] [Reference Citation Analysis]
15 Zhang Y, Sun S, Xu W, Yang R, Yang Y, Guo J, Ma K, Xu J. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling. Free Radic Biol Med 2021;180:52-62. [PMID: 34973363 DOI: 10.1016/j.freeradbiomed.2021.12.314] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Qin Q, Yang B, Liu J, Song E, Song Y. Polychlorinated biphenyl quinone exposure promotes breast cancer aerobic glycolysis: An in vitro and in vivo examination. J Hazard Mater 2021;424:127512. [PMID: 34736186 DOI: 10.1016/j.jhazmat.2021.127512] [Reference Citation Analysis]
17 Siddiqui R, Muhammad JS, Maciver SK, Khan NA. Crocodylus porosus Sera a Potential Source to Identify Novel Epigenetic Targets: In Silico Analysis. Veterinary Sciences 2022;9:210. [DOI: 10.3390/vetsci9050210] [Reference Citation Analysis]
18 Sun Y, Hu M, Wang F, Tan H, Hu J, Wang X, Wang B, Hu J, Li Y. Quantification of 2-NBDG, a probe for glucose uptake, in GLUT1 overexpression in HEK293T cells by LC-MS/MS. Anal Biochem 2021;631:114357. [PMID: 34469746 DOI: 10.1016/j.ab.2021.114357] [Reference Citation Analysis]
19 Naik A, Decock J. Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors. Front Oncol 2020;10:598626. [PMID: 33324565 DOI: 10.3389/fonc.2020.598626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Shen L, Hu G, Karner CM. Bioenergetic Metabolism In Osteoblast Differentiation. Curr Osteoporos Rep 2022. [PMID: 35112289 DOI: 10.1007/s11914-022-00721-2] [Reference Citation Analysis]
21 Zhao Z, Li G, Han Y, Li Y, Ji Z, Guo R, Yu X. Circular RNA ZNF609 enhances proliferation and glycolysis during glioma progression by miR-378b/SLC2A1 axis. Aging (Albany NY) 2021;13:21122-33. [PMID: 34520391 DOI: 10.18632/aging.203331] [Reference Citation Analysis]
22 Sharma S, Agnihotri N, Kumar S. Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.114943] [Reference Citation Analysis]
23 Wang M, Chen W, Chen J, Yuan S, Hu J, Han B, Huang Y, Zhou W. Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies. Eur J Med Chem 2021;220:113487. [PMID: 33933752 DOI: 10.1016/j.ejmech.2021.113487] [Reference Citation Analysis]
24 Fujii T, Katoh M, Ootsubo M, Nguyen OTT, Iguchi M, Shimizu T, Tabuchi Y, Shimizu Y, Takeshima H, Sakai H. Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular Na+ ,K+ -ATPase α3-isoform in human cancer cells. J Cell Physiol 2022. [PMID: 35511727 DOI: 10.1002/jcp.30762] [Reference Citation Analysis]
25 Gaál Z. MicroRNAs and Metabolism: Revisiting the Warburg Effect with Emphasis on Epigenetic Background and Clinical Applications. Biomolecules 2021;11:1531. [PMID: 34680164 DOI: 10.3390/biom11101531] [Reference Citation Analysis]
26 Zacksenhaus E, Egan SE. Progression to Metastasis of Solid Cancer. Cancers (Basel) 2021;13:717. [PMID: 33578666 DOI: 10.3390/cancers13040717] [Reference Citation Analysis]
27 Lu YY, Wu CH, Hong CH, Chang KL, Lee CH. GLUT-1 Enhances Glycolysis, Oxidative Stress, and Fibroblast Proliferation in Keloid. Life (Basel) 2021;11:505. [PMID: 34070830 DOI: 10.3390/life11060505] [Reference Citation Analysis]
28 Xie X, Lee J, Iwase T, Kai M, Ueno NT. Emerging drug targets for triple-negative breast cancer: A guided tour of the preclinical landscape. Expert Opin Ther Targets 2022. [PMID: 35574694 DOI: 10.1080/14728222.2022.2077188] [Reference Citation Analysis]
29 Wu Q, Nie DY, Ba-Alawi W, Ji Y, Zhang Z, Cruickshank J, Haight J, Ciamponi FE, Chen J, Duan S, Shen Y, Liu J, Marhon SA, Mehdipour P, Szewczyk MM, Dogan-Artun N, Chen W, Zhang LX, Deblois G, Prinos P, Massirer KB, Barsyte-Lovejoy D, Jin J, De Carvalho DD, Haibe-Kains B, Wang X, Cescon DW, Lupien M, Arrowsmith CH. PRMT inhibition induces a viral mimicry response in triple-negative breast cancer. Nat Chem Biol 2022. [PMID: 35578032 DOI: 10.1038/s41589-022-01024-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, Deng X, Wang Y, Fan C, Tang L, Zhang S, Gong Z, Wang F, Liao Q, Guo C, Li Y, Li X, Li G, Zeng Z, Xiong W. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer 2021;20:112. [PMID: 34465340 DOI: 10.1186/s12943-021-01409-4] [Reference Citation Analysis]
31 Yang H, Zhang MZ, Sun HW, Chai YT, Li X, Jiang Q, Hou J. A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Front Oncol 2021;11:783194. [PMID: 34869036 DOI: 10.3389/fonc.2021.783194] [Reference Citation Analysis]
32 Chen S, Gu J, Zhang Q, Hu Y, Ge Y. Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients. J Oncol 2021;2021:3375297. [PMID: 34992654 DOI: 10.1155/2021/3375297] [Reference Citation Analysis]
33 Zhang Z, Li X, Yang F, Chen C, Liu P, Ren Y, Sun P, Wang Z, You Y, Zeng YX, Li X. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun 2021;12:5872. [PMID: 34620861 DOI: 10.1038/s41467-021-26180-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Miyai M, Kanayama T, Hyodo F, Kinoshita T, Ishihara T, Okada H, Suzuki H, Takashima S, Wu Z, Hatano Y, Egashira Y, Enomoto Y, Nakayama N, Soeda A, Yano H, Hirata A, Niwa M, Sugie S, Mori T, Maekawa Y, Iwama T, Matsuo M, Hara A, Tomita H. Glucose transporter Glut1 controls diffuse invasion phenotype with perineuronal satellitosis in diffuse glioma microenvironment. Neurooncol Adv 2021;3:vdaa150. [PMID: 33506198 DOI: 10.1093/noajnl/vdaa150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Cheng H, Kuang S, Tan L, Sun S. Circ_0001955 plays a carcinogenic role in breast cancer via positively regulating GLUT1 via decoying miR-1299. Thorac Cancer 2022. [PMID: 35174654 DOI: 10.1111/1759-7714.14310] [Reference Citation Analysis]
36 Choi H, Na KJ. Different Glucose Metabolic Features According to Cancer and Immune Cells in the Tumor Microenvironment. Front Oncol 2021;11:769393. [PMID: 34966676 DOI: 10.3389/fonc.2021.769393] [Reference Citation Analysis]